Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4798 (MIR4798, also known as hsa-mir-4798 or hsa-miR-4798-3p) is a small, ~22-nucleotide, non-coding RNA molecule belonging to the family of microRNAs (miRNAs) found in humans[2][5][6][7]. microRNAs function as post-transcriptional regulators, binding to complementary sequences on messenger RNAs (mRNAs) to repress expression or promote mRNA degradation[5][6][7]. MIR4798 appears in profiling screens and has been studied as a circulating biomarker in myocardial infarction, where its blood levels increase after surgical intervention[2]. While its mechanistic roles are less established than those of other, more extensively researched microRNAs, like miR-1 or miR-133, the general functions of microRNAs include the regulation of cell proliferation, apoptosis, and inflammation[2][5][6]. Specific gene targets or disease mechanisms for MIR4798 remain to be elucidated in the scientific literature, and no drugs are known to directly target this miRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4798 (MIR4798).